Question 1

What is the catalog number for PKSI-527, Plasma kallikrein inhibitor (selective)?

Accepted Answer

The catalog number for PKSI-527, Plasma kallikrein inhibitor (selective) is TBI2220-5MG.

Question 2

What sizes are available for PKSI-527, Plasma kallikrein inhibitor (selective)?

Accepted Answer

PKSI-527, Plasma kallikrein inhibitor (selective) is available in the following size(s): 5 mg.

Question 3

Is PKSI-527, Plasma kallikrein inhibitor (selective) in stock?

Accepted Answer

PKSI-527, Plasma kallikrein inhibitor (selective) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

PKSI-527, Plasma kallikrein inhibitor (selective)

Product Specifications

Shipping Conditions

Frequently Asked Questions

Explore Other Products

Human IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker) (rIGHM/3802), CF647 conjugate, 0.1mg/mL

CD103 / Integrin alpha E (T-Cell Lymphoma & Hairy Cell Leukemia Marker) (ITGAE/2063), CF568 conjugate, 0.1mg/mL

Calprotectin (MRP14) (S100A9) (CAGB/426), 0.2mg/mL

Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker) (TYRP1/1986), 1mg/mL

Human IgA Immunoglobulin (IA761), CF543 conjugate, 0.1mg/mL

Bcl-2 (124), CF568 conjugate, 0.1mg/mL